Literature DB >> 7903974

Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus.

S R Tabet1, G M Goldbaum, T M Hooton, K D Eisenach, M D Cave, C M Nolan.   

Abstract

Analysis of restriction fragment length polymorphisms (RFLP) was used to investigate an increase in tuberculosis (TB) among noninstitutionalized human immunodeficiency virus (HIV)-infected persons in King County, Washington. Using the IS6110 insertion sequence, RFLP analysis was done on Mycobacterium tuberculosis isolates from 18 HIV-infected patients and 10 randomly selected patients without HIV risk factors. Six HIV-infected patients with the same M. tuberculosis strain had contact at one or more of three bars as their only common exposure. Two other HIV-infected persons, a patient and a health care worker who had close contact, had matching strains. Isolates from the 10 remaining HIV-infected patients and the 10 patients without HIV risk factors had different DNA patterns. Analysis of RFLP patterns revealed a community outbreak of TB among HIV-infected persons who had not been previously linked following conventional investigation by the health department. This technique deserves further evaluation as an epidemiologic tool in the investigation of TB.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7903974     DOI: 10.1093/infdis/169.1.189

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

Review 1.  How molecular epidemiology has changed what we know about tuberculosis.

Authors:  M Kato-Maeda; P M Small
Journal:  West J Med       Date:  2000-04

2.  Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients.

Authors:  S Lockman; J D Sheppard; C R Braden; M J Mwasekaga; C L Woodley; T A Kenyon; N J Binkin; M Steinman; F Montsho; M Kesupile-Reed; C Hirschfeldt; M Notha; T Moeti; J W Tappero
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  What it takes to control tuberculosis.

Authors:  C R Horsburgh
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

4.  Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis.

Authors:  F Chaves; Z Yang; H el Hajj; M Alonso; W J Burman; K D Eisenach; F Dronda; J H Bates; M D Cave
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Transmission of leprosy in Qiubei County, Yunnan, China: insights from an 8-year molecular epidemiology investigation.

Authors:  Xiaoman Weng; Jason Vander Heiden; Yan Xing; Jian Liu; Varalakshmi Vissa
Journal:  Infect Genet Evol       Date:  2010-12-01       Impact factor: 3.342

6.  Spacer oligonucleotide typing of Mycobacterium bovis strains from cattle and other animals: a tool for studying epidemiology of tuberculosis.

Authors:  A Aranaz; E Liébana; A Mateos; L Dominguez; D Vidal; M Domingo; O Gonzolez; E F Rodriguez-Ferri; A E Bunschoten; J D Van Embden; D Cousins
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

Review 7.  Escalating threat from tuberculosis: the third epidemic.

Authors:  A S Malin; K P McAdam
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

8.  Mycobacterium tuberculosis transmission between cluster members with similar fingerprint patterns.

Authors:  Kashef Ijaz; Zhenhua Yang; H Stewart Matthews; Joseph H Bates; M Donald Cave
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

9.  DNA fngerprinting of Mycobacterium tuberculosis: lessons learned and implications for the future.

Authors:  Scott J N McNabb; Christopher R Braden; Thomas R Navin
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

Review 10.  New developments in tuberculosis and HIV infection: an opportunity for prevention.

Authors:  J R Curtis; T M Hooton; C M Nolan
Journal:  J Gen Intern Med       Date:  1994-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.